» Articles » PMID: 15973668

Cognitive Impairment, Fatigue, and Cytokine Levels in Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2005 Jun 24
PMID 15973668
Citations 181
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The objective of the current study was to assess the correlations between cognitive function, fatigue, quality of life, and circulating cytokine levels in patients with acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS).

Methods: Fifty-four patients with AML/MDS were seen for pretreatment evaluation of their cognitive function and symptoms. Fifty percent of the sample was reevaluated 1 month later, when response to protocol chemotherapy was assessed.

Results: A significant proportion of patients had impaired cognitive function prior to the institution of chemotherapy. Sixty-five percent of patients also experienced significant fatigue. Levels of the circulating cytokines interleukin 1 (IL-1), IL-1 receptor antagonist (IL-1RA), IL-6, IL-8, and tumor necrosis factor-alpha (TNF-alpha) were elevated highly compared with normal controls. Higher IL-6 levels were associated with poorer executive function, whereas higher IL-8 levels were associated with better memory performance. IL-6, IL-1RA, and TNF-alpha levels were related to ratings of fatigue. Fatigue and cognitive dysfunction were unrelated. Hemoglobin levels were not associated significantly with either cognitive dysfunction or fatigue. Patients who obtained a complete response tended to have better fine motor control at baseline and lower circulating IL-1 levels. Treatment did not have a significant impact on cognition, although fatigue levels tended to increase.

Conclusions: Patients with AML/MDS are highly symptomatic and experience cognitive impairment and fatigue before the initiation of their treatment. The current results indicated a correlation between these symptoms and levels of circulating cytokines, providing some support to the hypothesis that cancer-related symptoms are related at least in part to cytokine-immunologic activation. Elucidation of immunologic correlates of symptoms will allow for targeted interventions.

Citing Articles

Cross-Cultural Adaptation and Validation of the Portuguese Version of the Metacognitive Prospective Memory Inventory-Short Form (MPMI-s) in Non-Central Nervous System Cancer Patients.

Santos F, Bartolo A, Fernandes S, Oliveira A, Caetano A, Silva I Healthcare (Basel). 2025; 13(5).

PMID: 40077025 PMC: 11898906. DOI: 10.3390/healthcare13050463.


A Scoping Review on Cognition in Myelodysplastic Syndromes: Advances and Challenges.

Tsiakiri A, Frigkas K, Vlotinou P, Papoutselis M, Christidi F, Karavasilis E Med Sci (Basel). 2025; 13(1).

PMID: 39982240 PMC: 11843857. DOI: 10.3390/medsci13010015.


Extracellular vesicles released by ALL patients contain HNE-adducted proteins: Implications of collateral damage.

Ho J, Sukati S, Taylor T, Carter S, Fuller B, Marmo A Free Radic Biol Med. 2024; 227:312-321.

PMID: 39643137 PMC: 11786608. DOI: 10.1016/j.freeradbiomed.2024.12.006.


Cancer-related cognitive impairment in older adults with acute myeloid leukemia treated with hypomethylating agents and venetoclax chemotherapy: a longitudinal descriptive study.

Chan Y, Cho Y, Hirschey R, Piepmeier A, Bender C, Anderson R Support Care Cancer. 2024; 32(7):485.

PMID: 38960966 PMC: 11311204. DOI: 10.1007/s00520-024-08673-2.


Molecular Regulation of Fetal Brain Development in Inbred and Congenic Mouse Strains Differing in Longevity.

Islam M, Behura S Genes (Basel). 2024; 15(5).

PMID: 38790233 PMC: 11121069. DOI: 10.3390/genes15050604.